California State Teachers Retirement System (CalSTRS)
GEVA

California State Teachers Retirement System (CalSTRS)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-42,563
Closed -$4.15M – 3139
2015
Q1 		$4.15M Buy
42,563
+2,700
+7% +$286K 0.01% 1118
2014
Q4 		$3.7M Sell
39,863
-1,147
-3% -$90.5K 0.01% 1193
2014
Q3 		$2.82M Buy
41,010
+1,940
+5% +$139K 0.01% 1331
2014
Q2 		$4.09M Buy
39,070
+1,500
+4% +$128K 0.01% 1120
2014
Q1 		$3.12M Buy
37,570
+2,800
+8% +$259K 0.01% 1228
2013
Q4 		$2.25M Buy
34,770
+4,200
+14% +$249K 0.01% 1439
2013
Q3 		$1.94M Buy
30,570
+800
+3% +$39.4K 0.01% 1490
2013
Q2 		$1.25M Buy
+29,770
New +$1.36M ﹤0.01% 1711

California State Teachers Retirement System (CalSTRS)'s GEVA Position: Q2 2015 in Review

California State Teachers Retirement System (CalSTRS) sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 42,563 shares — an estimated $4.15M sold.

California State Teachers Retirement System (CalSTRS) first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $4.15M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • California State Teachers Retirement System (CalSTRS) reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 42,563 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $4.15M.
  • California State Teachers Retirement System (CalSTRS) first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • California State Teachers Retirement System (CalSTRS)'s SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $4.15M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2015, filed 3 Aug 2015.